Biogen Non-GAAP EPS of $3.40 beats by $0.12, revenue of $2.46B beats by $120M
Biogen (NASDAQ:BIIB): Q1  Non-GAAP EPS of $3.40  beats by $0.12.
Revenue of $2.46B (-2.8% Y/Y)  beats by $120M.
FY 23 outlook: Revenue to report mid-single digit decline vs FY22.
Adj EPS of $15.00-$16.00 vs $15.76